Hongxia Du
Tianjin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Qishen Yiqi alleviates periostin-mediated cardiac fibrosis and hypertrophy in Dahl hypertensive rat hearts and angiotensin II-induced cardiac organoids.
Journal: Frontiers in pharmacology
Published: September 05, 2024
Corrigendum: Tengdan Capsule Prevents Hypertensive Kidney Damage in SHR by Inhibiting Periostin-Mediated Renal Fibrosis.
Journal: Frontiers in pharmacology
Published: November 13, 2021
QiShenYiQi ameliorates salt-induced hypertensive nephropathy by balancing ADRA1D and SIK1 expression in Dahl salt-sensitive rats.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 15, 2021
Recovery of post-stroke cognitive and motor deficiencies by Shuxuening injection via regulating hippocampal BDNF-mediated Neurotrophin/Trk Signaling.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 10, 2021
Tengdan Capsule Prevents Hypertensive Kidney Damage in SHR by Inhibiting Periostin-Mediated Renal Fibrosis.
Journal: Frontiers in pharmacology
Published: December 06, 2020
Restoration of early deficiency of axonal guidance signaling by guanxinning injection as a novel therapeutic option for acute ischemic stroke.
Journal: Pharmacological research
Published: October 16, 2020
Shuxuening injection facilitates neurofunctional recovery via down-regulation of G-CSF-mediated granulocyte adhesion and diapedesis pathway in a subacute stroke mouse model.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: February 04, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026